human
adenovirus
hadv
medic
import
respiratori
pathogen
among
recogn
speci
ag
speci
c
hadv
serotyp
global
endem
infect
peopl
earli
life
speci
c
hadv
infect
often
subclin
mild
lead
persist
shed
gastrointestin
upper
respiratori
tract
also
caus
sever
dissemin
diseas
newborn
immunocompromis
person
rapid
quantit
detect
identif
viru
would
help
guid
therapeut
intervent
end
develop
quantit
typespecif
realtim
pcr
qpcr
assay
target
hadv
hexon
gene
typespecif
qpcr
assay
reproduc
detect
copiesreact
quantifi
hexon
recombin
plasmid
linear
dynam
rang
log
unit
copi
nonspecif
amplif
observ
concentr
nucleic
acid
hadv
type
common
respiratori
pathogen
previous
type
hadv
field
isol
posit
clinic
specimen
detect
correctli
identifi
type
qpcr
assay
sampl
hadv
type
sampl
type
identifi
confirm
amplicon
sequenc
speci
c
hadv
qpcr
assay
permit
rapid
sensit
specif
quantit
detect
identif
four
recogn
endem
hadv
togeth
previous
develop
qpcr
assay
epidem
respiratori
hadv
assay
provid
conveni
altern
classic
type
method
publish
elsevi
bv
human
adenovirus
hadv
caus
wide
spectrum
diseas
respiratori
ocular
gastrointestin
tract
hadv
classifi
within
famili
adenovirida
genu
mastadenoviru
divid
seven
speci
ag
recogn
type
harrach
et
al
clinic
symptom
diseas
sever
epidemiolog
pattern
infect
often
determin
viru
speci
type
speci
c
hadv
serotyp
global
endem
infect
peopl
earli
life
schmitz
et
al
approxim
half
hadv
identifi
three
year
studi
clinic
sever
infect
among
us
civilian
speci
c
gray
et
al
uniqu
speci
c
virus
establish
infect
mucosaassoci
lymphoid
tissu
persist
without
clinic
evid
life
garnett
et
al
infect
immunocompet
person
virus
often
subclin
lead
mild
acut
respiratori
ill
howev
immunosuppress
person
risk
sever
dissemin
lifethreaten
diseas
primari
infect
viru
reactiv
ison
wall
et
al
immunolog
naiv
newborn
abzug
levin
cassir
et
al
hadv
tradit
type
neutral
andor
hemagglutin
inhibit
use
typespecif
hyperimmun
anim
antisera
varieti
molecular
method
sinc
replac
immunotyp
includ
genom
restrict
analysi
adrian
et
al
pcrcoupl
microarray
lin
et
al
pcrfragment
length
analysi
adhikari
et
al
ebner
et
al
electrospray
ioniz
mass
spectrometri
blyn
et
al
partial
sequenc
specif
target
gene
lu
erdman
mccarthi
et
al
recent
full
genom
sequenc
use
next
gener
molecular
method
torr
et
al
howev
method
often
complex
time
consum
optim
design
viral
load
determin
import
monitor
hadv
diseas
progress
therapeut
efficaci
quantit
realtim
pcr
qpcr
propos
rapid
sensit
wide
avail
technolog
detect
identif
hadv
suit
clinic
diagnost
set
heim
et
al
metzgar
et
al
introduc
typespecif
qpcr
assay
identif
hadv
often
associ
outbreak
acut
respiratori
diseas
speci
b
type
speci
e
type
facilit
rapid
public
health
respons
lu
et
al
studi
describ
develop
valid
qpcr
assay
endem
speci
c
hadv
hadv
prototyp
strain
geograph
tempor
divers
respiratori
specimen
nasopharyng
oropharyng
swab
nasal
wash
tracheal
aspir
blood
plasma
stool
field
isol
collect
outbreak
investig
routin
surveil
previous
determin
posit
n
n
n
n
gener
pcr
partial
hexon
gene
sequenc
lu
erdman
avail
cdc
archiv
test
evalu
assay
specif
also
test
assay
high
concentr
potenti
respiratori
pathogen
includ
respiratori
syncyti
viru
long
human
metapneumoviru
parainfluenza
virus
rhinoviru
human
coronavirus
influenza
virus
b
cytomegaloviru
herp
simplex
viru
human
bocaviru
clinic
specimen
streptococcu
pneumonia
hemophilu
influenza
pool
nasal
wash
specimen
predict
contain
divers
human
microbiolog
flora
consent
healthi
new
militari
recruit
hexon
gene
sequenc
hadv
prototyp
field
strain
avail
genbank
ncbinlm
align
typespecif
conserv
region
identifi
multipl
primerprob
set
design
use
primer
express
tm
softwar
ver
appli
biosystem
foster
citi
ca
give
predict
typespecif
amplif
show
major
nonspecif
homolog
blast
analysi
hydrolysi
probe
label
end
fam
end
black
hole
quencher
tm
biosearch
technolog
inc
novato
ca
optim
primerprob
concentr
assay
determin
checkerboard
titrat
primerprob
combin
give
best
overal
perform
limit
panel
hadv
evalu
primerprob
set
perform
best
condit
describ
identifi
crossreact
chosen
studi
tabl
primer
probe
sequenc
use
detect
hadv
panqpcr
heim
et
al
heim
et
al
total
nucleic
acid
tna
extract
prepar
l
viru
isol
l
clinic
specimen
use
nuclisen
minimag
easymag
extract
system
follow
manufactur
instruct
durham
nc
qpcr
assay
run
follow
condit
previous
describ
lu
et
al
briefli
l
reaction
mixtur
prepar
ad
l
sampl
nucleic
acid
extract
l
iq
tm
supermix
biorad
hercul
ca
contain
optim
concentr
primerprob
tabl
thermocycl
perform
stratagen
qpcr
system
agil
technolog
santa
clara
ca
appli
biosystem
fast
dx
realtim
pcr
system
thermo
fisher
scientif
carlsbad
ca
program
min
c
activ
itaq
dna
polymeras
cycl
c
min
c
posit
test
result
assign
welldefin
fluoresc
curv
cross
threshold
within
cycl
recombin
dna
plasmid
contain
sequenceconfirm
full
hexon
gene
prototyp
strain
construct
commerci
sourc
dna
technolog
inc
gaithersburg
md
cellom
technolog
baltimor
md
use
posit
control
analyt
sensit
studi
hrp
quantifi
use
qubit
tm
dsdna
br
assay
kit
qubit
fluoromet
thermo
fisher
scientif
standard
curv
quantit
assess
prepar
replic
serial
dilut
copiesl
hrp
mm
te
buffer
contain
gml
her
sperm
dna
promega
madison
wi
optim
qpcr
assay
first
evalu
serial
dilut
quantifi
hrp
estim
limit
detect
lod
serial
dilut
respect
hrp
contain
copiesreact
test
replic
typespecif
panqpcr
assay
gave
linear
dynam
rang
log
unit
copi
amplif
effici
exceed
fig
typespecif
qpcr
assay
could
reproduc
detect
hrp
copiesreact
tabl
hadv
panqpcr
assay
show
compar
lod
typespecif
qpcr
assay
primerprob
qpcr
assay
evalu
silico
hadv
hexon
gene
sequenc
publish
genbank
signific
sequenc
homolog
observ
hadv
type
would
predict
crossreact
blast
analys
found
signific
homolog
human
genom
human
microbi
flora
would
possibl
lead
fals
posit
result
qpcr
assay
test
concentr
genom
dna
c
valu
hadv
panqpcr
hadv
prototyp
strain
assess
typespecif
crossreact
detect
tabl
specif
qpcr
panel
assess
test
laboratori
cultur
posit
clinic
specimen
known
contain
high
concentr
viral
bacteri
pathogen
may
present
respiratori
tract
describ
materi
method
posit
result
obtain
sampl
except
human
nasal
wash
pool
weak
posit
result
c
obtain
hadvpan
assay
respect
subsequ
pcr
partial
hexon
gene
sequenc
confirm
low
level
pool
indic
viru
present
upper
respiratori
tract
one
individu
sampl
assess
perform
qpcr
assay
divers
hadv
field
isol
posit
clinic
specimen
tna
previous
type
hadv
strain
test
assay
tabl
hadv
detect
sampl
correctli
identifi
type
respect
qpcr
assay
howev
differ
hadv
type
found
clinic
specimen
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
plot
serial
dilut
respect
hexon
recombin
plasmid
rang
copiesreact
obtain
hadv
typespecif
blue
pan
red
qpcr
assay
plot
insert
show
calcul
linear
correl
coeffici
r
amplif
effici
assay
hadv
qpcr
assay
specif
hadv
qpcr
assay
hadvpan
hadv
qpcr
assay
result
hadv
field
isol
posit
clinic
specimen
c
c
hadv
type
found
one
specimen
c
c
c
qpcr
find
confirm
sequenc
respect
qpcr
amplicon
case
predomin
type
type
lower
c
valu
identifi
routin
method
gener
pcr
partial
hexon
gene
sequenc
lu
erdman
previou
studi
describ
develop
typespecif
qpcr
assay
epidem
respiratori
hadv
type
lu
et
al
studi
expand
assay
panel
includ
typespecif
qpcr
assay
endem
speci
c
virus
speci
c
hadv
caus
sever
dissemin
lifethreaten
diseas
immunecompromis
patient
particularli
transplant
recipi
rapid
quantit
detect
identif
endem
speci
c
hadv
among
newborn
transplant
recipi
sever
dissemin
diseas
would
help
guid
therapeut
intervent
four
speci
c
hadv
assay
prove
sensit
specif
allow
quantit
assess
viral
load
base
standard
curv
analysi
use
quantifi
hpr
realtim
pcr
technolog
typespecif
identif
hadv
first
employ
jone
et
al
detect
identifi
use
joint
biolog
agent
identif
diagnost
system
biofir
diagnost
salt
lake
citi
utah
lightcycl
roch
indianapoli
platform
howev
assay
predict
time
less
sensit
correspond
qpcr
assay
also
show
nonspecif
crossreact
among
four
viru
type
furthermor
assay
develop
valid
platform
common
use
outsid
us
depart
defenseaffili
laboratori
among
clinic
specimen
evalu
studi
found
contain
multipl
speci
c
hadv
type
contrast
routin
type
method
gener
pcr
sanger
sequenc
partial
region
hexon
gene
abl
identifi
predomin
hadv
type
case
kore
et
al
kroe
et
al
shown
sequenti
emerg
multipl
hadv
pediatr
stem
cell
transplant
make
simultan
detect
hadv
coinfect
especi
challeng
typespecif
qpcr
assay
prove
use
type
identif
manag
mix
hadv
infect
immunocompromis
person
may
facilit
futur
studi
better
defin
full
complex
hadv
infect
popul
despit
advantag
qpcr
assay
limit
although
expand
assay
panel
cover
hadv
type
frequent
associ
dissemin
diseas
immunosuppress
person
speci
speci
b
virus
may
also
caus
sever
infect
popul
would
identifi
madisch
et
al
furthermor
sinc
qpcr
assay
target
short
sequenc
hadv
hexon
gene
novel
hexonfib
recombin
virus
would
recogn
exampl
rare
recombin
speci
c
hadv
design
type
recent
report
contain
uniqu
hexon
gene
fiber
gene
walsh
et
al
would
identifi
assay
conclus
qpcr
assay
permit
sensit
specif
quantit
detect
identif
four
speci
c
hadv
allow
differenti
hadv
coinfect
difficult
distinguish
method
togeth
previous
develop
qpcr
assay
epidem
respiratori
hadv
assay
provid
rapid
conveni
altern
classic
type
method
find
conclus
report
author
necessarili
repres
offici
posit
center
diseas
control
prevent
